Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.
2.

Effect of supplementary calcium phosphate on plasma gastrointestinal hormones in a double-blind, placebo-controlled, cross-over human study.

Trautvetter U, Jahreis G.

Br J Nutr. 2014 Jan 28;111(2):287-93. doi: 10.1017/S0007114513002341. Epub 2013 Jul 22.

PMID:
23871132
3.

A combination of calcium phosphate and probiotics beneficially influences intestinal lactobacilli and cholesterol metabolism in humans.

Trautvetter U, Ditscheid B, Kiehntopf M, Jahreis G.

Clin Nutr. 2012 Apr;31(2):230-7. doi: 10.1016/j.clnu.2011.09.013. Epub 2011 Oct 20.

PMID:
22019281
4.

Effect of calcium phosphate and vitamin D₃ supplementation on bone remodelling and metabolism of calcium, phosphorus, magnesium and iron.

Trautvetter U, Neef N, Leiterer M, Kiehntopf M, Kratzsch J, Jahreis G.

Nutr J. 2014 Jan 17;13:6. doi: 10.1186/1475-2891-13-6.

5.

Cholesterol metabolism is affected by calcium phosphate supplementation in humans.

Ditscheid B, Keller S, Jahreis G.

J Nutr. 2005 Jul;135(7):1678-82.

8.

Effects of short-chain fructo-oligosaccharides on glucose and lipid metabolism in mild hypercholesterolaemic individuals.

Giacco R, Clemente G, Luongo D, Lasorella G, Fiume I, Brouns F, Bornet F, Patti L, Cipriano P, Rivellese AA, Riccardi G.

Clin Nutr. 2004 Jun;23(3):331-40.

PMID:
15158296
9.

Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.

Asemi Z, Foroozanfard F, Hashemi T, Bahmani F, Jamilian M, Esmaillzadeh A.

Clin Nutr. 2015 Aug;34(4):586-92. doi: 10.1016/j.clnu.2014.09.015. Epub 2014 Oct 3.

PMID:
25300649
10.
11.

Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes.

Kipnes M, Dandona P, Tripathy D, Still JG, Kosutic G.

Diabetes Care. 2003 Feb;26(2):421-6.

PMID:
12547873
12.

Effects of carnitine supplementation on flow-mediated dilation and vascular inflammatory responses to a high-fat meal in healthy young adults.

Volek JS, Judelson DA, Silvestre R, Yamamoto LM, Spiering BA, Hatfield DL, Vingren JL, Quann EE, Anderson JM, Maresh CM, Kraemer WJ.

Am J Cardiol. 2008 Nov 15;102(10):1413-7. doi: 10.1016/j.amjcard.2008.07.022. Epub 2008 Sep 11.

PMID:
18993165
13.

Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects.

Knop FK, Konings E, Timmers S, Schrauwen P, Holst JJ, Blaak EE.

Diabet Med. 2013 Oct;30(10):1214-8. doi: 10.1111/dme.12231. Epub 2013 Jun 7.

PMID:
23663119
14.

Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: a randomised controlled trial in postmenopausal women.

Bristow SM, Gamble GD, Stewart A, Horne L, House ME, Aati O, Mihov B, Horne AM, Reid IR.

Br J Nutr. 2014 Nov 28;112(10):1611-20. doi: 10.1017/S0007114514002785. Epub 2014 Oct 2.

PMID:
25274192
15.

Oral calcium phosphate: a new therapy for Crigler-Najjar disease?

Van der Veere CN, Jansen PL, Sinaasappel M, Van der Meer R, Van der Sijs H, Rammeloo JA, Goyens P, Van Nieuwkerk CM, Oude Elferink RP.

Gastroenterology. 1997 Feb;112(2):455-62.

PMID:
9024299
16.

Modification of intracellular calcium and plasma renin by dietary calcium in men.

Petrov V, Lijnen P.

Am J Hypertens. 1999 Dec;12(12 Pt 1-2):1217-24.

PMID:
10619585
17.

The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients.

Flint A, Kapitza C, Hindsberger C, Zdravkovic M.

Adv Ther. 2011 Mar;28(3):213-26. doi: 10.1007/s12325-010-0110-x. Epub 2011 Feb 17.

PMID:
21340616
18.

A mixed diet supplemented with L-arabinose does not alter glycaemic or insulinaemic responses in healthy human subjects.

Halschou-Jensen K, Bach Knudsen KE, Nielsen S, Bukhave K, Andersen JR.

Br J Nutr. 2015 Jan 14;113(1):82-8. doi: 10.1017/S0007114514003407. Epub 2014 Nov 17.

PMID:
25400106
19.

Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, cross-over trial.

Hermansen K, Bækdal TA, Düring M, Pietraszek A, Mortensen LS, Jørgensen H, Flint A.

Diabetes Obes Metab. 2013 Nov;15(11):1040-8. doi: 10.1111/dom.12133. Epub 2013 Jun 11.

20.

Supplemental Content

Support Center